Patents by Inventor Stephen Schilling

Stephen Schilling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL INHIBITORS OF MEPRIN ALPHA AND BETA
    Publication number: 20210198189
    Abstract: The present invention relates to novel hydroxamic acid derivatives as inhibitors of meprin ? and/or ?, pharmaceutical compositions comprising such compounds, methods for treatment or prophylaxis of diseases or conditions, especially such that are related to meprin ? and/or ?, and compounds and pharmaceutical compositions for use in such methods.
    Type: Application
    Filed: March 8, 2021
    Publication date: July 1, 2021
    Applicant: Vivoryon Therapeutics AG
    Inventors: Michael Wermann, Mirko Buchholz, Hans-Ulrich Demuth, Daniel Ramsbeck, Dagmar Schlenzig, Stephen Schilling
  • Inhibitors of meprin ? and ?
    Patent number: 10975019
    Abstract: The present invention relates to novel hydroxamic acid derivatives as inhibitors of meprin ? and/or ?, pharmaceutical compositions comprising such compounds, methods for treatment or prophylaxis of diseases or conditions, especially such that are related to meprin ? and/or ?, and compounds and pharmaceutical compositions for use in such methods.
    Type: Grant
    Filed: April 18, 2017
    Date of Patent: April 13, 2021
    Assignee: Vivoryon Therapeutics AG
    Inventors: Michael Wermann, Mirko Buchholz, Hans-Ulrich Demuth, Daniel Ramsbeck, Dagmar Schlenzig, Stephen Schilling
  • NOVEL INHIBITORS OF MEPRIN ALPHA AND BETA
    Publication number: 20190127317
    Abstract: The present invention relates to novel hydroxamic acid derivatives as inhibitors of meprin ? and/or ?, pharmaceutical compositions comprising such compounds, methods for treatment or prophylaxis of diseases or conditions, especially such that are related to meprin ? and/or ?, and compounds and pharmaceutical compositions for use in such methods.
    Type: Application
    Filed: April 18, 2017
    Publication date: May 2, 2019
    Inventors: Michael Wermann, Mirko Buchholz, Hans-Ulrich Demuth, Daniel Ramsbeck, Dagmar Schlenzig, Stephen Schilling
  • CAMOUFLAGE SYSTEMS AND METHODS OF MAKING CAMOUFLAGE SYSTEMS
    Publication number: 20190110540
    Abstract: A camouflage system and methods of making camouflage systems. The camouflage comprises a series of image layers that are sequenced and superimposed to create a repeatable composite image that reduces visibility to first set of sensors (e.g., an animal's eyes) while enhancing visibility to a second set of sensors (e.g., a human's eyes). The camouflage includes a base set of layers that may be used to mimic a macro-environment, a pattern layer, and a detail set of layers that may be used to mimic a microenvironment. The camouflage may be presented in various color schemes, with one suitable scheme being a range of colors centered around safety orange (Pantone 152) and a range of colors from grey to black.
    Type: Application
    Filed: October 17, 2018
    Publication date: April 18, 2019
    Inventors: Jeffrey David Sarcone Martin, James Stephen Schilling
  • ANTIBODIES DIRECTED AGAINST PYROGLUTAMATE MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1 N1pE)
    Publication number: 20100119478
    Abstract: Monoclonal antibodies which bind specifically to the proinflammatory cytokine pyroglutamate MCP-1 (MCP-1 N1pE) are described.
    Type: Application
    Filed: August 20, 2009
    Publication date: May 13, 2010
    Applicant: PROBIODRUG AG
    Inventors: Holger Cynis, Hans-Ulrich Demuth, Jens-Ulrich Rahfeld, Kathrin Gans, Stephen Schilling, Sonja Kampfer